Straits Times Index
3,187.66 +32.97 (+1.05%) S&P 500
5,012.49 -9.72 (-0.19%) Dow
37,776.87 +23.56 (+0.06%) Nasdaq
15,622.24 -61.14 (-0.39%) Bitcoin USD
63,308.45 +2,074.30 (+3.39%) CMC Crypto 200
885.54 0.00 (0.00%)
Sanofi (SAN.PA)
| Previous close | 86.18 |
| Open | 86.06 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 85.07 - 86.15 |
| 52-week range | 80.60 - 105.18 |
| Volume | |
| Avg. volume | 1,354,235 |
| Market cap | 106.387B |
| Beta (5Y monthly) | 0.45 |
| PE ratio (TTM) | 19.82 |
| EPS (TTM) | 4.30 |
| Earnings date | 25 Apr 2024 |
| Forward dividend & yield | 3.76 (4.36%) |
| Ex-dividend date | 13 May 2024 |
| 1y target est | 103.40 |
GlobeNewswirePress Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis
New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis Data support frexalimab as a potential first-in-class, high-efficacy, non-lymphocyte depleting treatment for relapsing multiple sclerosis96% of participants receiving high-dose intravenous frexalimab had no new Gd+ T1 lesions and an annualized relapse rate of 0.04 after 48 weeksSanofi has initiated global phase 3 studies of frexalimab in relapsing MS and non-relapsing secondary progressive MS
- GlobeNewswire
Sanofi: Information concerning the total number of voting rights and shares - March 2024
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority) Sanofia French société anonyme with a registered share capital of 2,529,599,938 €Registered office : 46, avenue de la Grande Armée - 75017 Paris - FranceRegistered at the Paris Commercial and Companies Regi
- GlobeNewswire
Sanofi - AGM 30.04.2024 - Availability of Preparatory documents
COMBINED GENERAL MEETING OF APRIL 30, 2024 AVAILABILITY OF PREPARATORY DOCUMENTS The Company’s shareholders are invited to attend the Combined General Meeting to be held on Thursday April 30, 2024 at 2:30 p.m. (CET) at the Palais des Congrès – Amphithéâtre Bleu – 2, place de la Porte Maillot – 75017 Paris. The notice of meeting (avis de réunion), including the agenda and the draft resolutions as well as the terms and conditions for participating and voting in the meeting, was published on the we
